24.86
price down icon4.42%   -1.15
pre-market  Vorhandelsmarkt:  25.21   0.35   +1.41%
loading
Schlusskurs vom Vortag:
$26.01
Offen:
$25.76
24-Stunden-Volumen:
6.83M
Relative Volume:
1.88
Marktkapitalisierung:
$3.27B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-99.15M
KGV:
-26.73
EPS:
-0.93
Netto-Cashflow:
$-74.25M
1W Leistung:
-7.79%
1M Leistung:
-7.86%
6M Leistung:
-41.26%
1J Leistung:
-52.86%
1-Tages-Spanne:
Value
$23.80
$25.96
1-Wochen-Bereich:
Value
$23.80
$27.01
52-Wochen-Spanne:
Value
$18.92
$81.73

Viking Therapeutics Inc Stock (VKTX) Company Profile

Name
Firmenname
Viking Therapeutics Inc
Name
Telefon
858-704-4660
Name
Adresse
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Name
Mitarbeiter
46
Name
Twitter
@viking_vktx
Name
Nächster Verdiensttermin
2024-10-23
Name
Neueste SEC-Einreichungen
Name
VKTX's Discussions on Twitter

Vergleichen Sie VKTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VKTX
Viking Therapeutics Inc
24.86 3.27B 0 -99.15M -74.25M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.54 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
511.92 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.13 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
540.76 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.51 28.51B 3.81B -644.79M -669.77M -6.24

Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-29 Eingeleitet Cantor Fitzgerald Overweight
2025-04-08 Eingeleitet Goldman Neutral
2025-02-13 Eingeleitet Scotiabank Sector Outperform
2025-02-07 Eingeleitet Citigroup Neutral
2024-12-02 Eingeleitet Piper Sandler Overweight
2024-11-22 Eingeleitet B. Riley Securities Buy
2024-11-04 Bestätigt H.C. Wainwright Buy
2024-09-11 Eingeleitet JP Morgan Overweight
2024-06-27 Eingeleitet Morgan Stanley Overweight
2024-05-16 Hochstufung Raymond James Outperform → Strong Buy
2024-03-26 Bestätigt Oppenheimer Outperform
2024-03-07 Eingeleitet Jefferies Buy
2024-02-28 Bestätigt Oppenheimer Outperform
2023-05-31 Fortgesetzt ROTH MKM Buy
2023-03-28 Bestätigt Maxim Group Buy
2023-03-17 Eingeleitet Stifel Buy
2021-07-29 Fortgesetzt BTIG Research Buy
2021-05-25 Herabstufung Raymond James Strong Buy → Outperform
2020-06-05 Eingeleitet BMO Capital Markets Outperform
2020-05-05 Eingeleitet Chardan Capital Markets Buy
2020-05-01 Eingeleitet BTIG Research Buy
2019-07-16 Eingeleitet Oppenheimer Outperform
2019-06-25 Eingeleitet Stifel Buy
2019-03-29 Hochstufung SVB Leerink Mkt Perform → Outperform
2019-03-14 Bestätigt Maxim Group Buy
2019-02-22 Eingeleitet SVB Leerink Mkt Perform
2018-12-12 Eingeleitet B. Riley FBR Buy
2018-11-19 Hochstufung Raymond James Outperform → Strong Buy
2018-09-18 Bestätigt H.C. Wainwright Buy
2018-09-18 Bestätigt Maxim Group Buy
2018-09-18 Bestätigt Raymond James Outperform
2018-07-20 Eingeleitet SunTrust Buy
2018-06-28 Eingeleitet Raymond James Outperform
2018-06-01 Bestätigt Laidlaw Buy
2018-05-31 Bestätigt Maxim Group Buy
2018-03-26 Fortgesetzt H.C. Wainwright Buy
2017-11-28 Bestätigt Maxim Group Buy
2017-11-21 Eingeleitet ROTH Capital Buy
Alle ansehen

Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten

pulisher
Jun 18, 2025

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

(VKTX) Proactive Strategies - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 17, 2025

Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200% - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - MSN

Jun 16, 2025
pulisher
Jun 13, 2025

Viking Therapeutics (VKTX) Rises on Expected Developments - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

We're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash Wisely - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? - AOL.com

Jun 12, 2025
pulisher
Jun 10, 2025

Investors Are Gobbling Up Shares of These 10 Firms - Insider Monkey

Jun 10, 2025
pulisher
Jun 10, 2025

Viking Therapeutics (VKTX) to Participate in B. Riley's Montreal Meeting | VKTX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)? - MSN

Jun 09, 2025
pulisher
Jun 08, 2025

Jim Cramer Nailed These 11 Stock Predictions - Insider Monkey

Jun 08, 2025
pulisher
Jun 08, 2025

1 Stock Down 34% This Year to Buy and Hold - AOL.com

Jun 08, 2025
pulisher
Jun 05, 2025

Transcript : Viking Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 11 - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

July 25th Options Now Available For Viking Therapeutics (VKTX) - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

(VKTX) Investment Analysis - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 03, 2025

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - sharewise

Jun 03, 2025
pulisher
Jun 02, 2025

Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential - Seeking Alpha

Jun 02, 2025
pulisher
Jun 02, 2025

Could Viking Therapeutics Become the Next Eli Lilly? - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

3 Best Growth Stocks to Buy in June - The Motley Fool

Jun 02, 2025
pulisher
May 30, 2025

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside? - MSN

May 30, 2025
pulisher
May 30, 2025

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

SA analyst upgrades: NVDA, DJT, VKTX, BRK.A, BEAM (NVDA:NASDAQ) - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade) - Seeking Alpha

May 29, 2025
pulisher
May 28, 2025

Viking Therapeutics to Participate at Upcoming Investor Conferen - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Viking Therapeutics to Participate at Upcoming Investor Conferences | VKTX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Viking Therapeutics to Participate at Upcoming Investor Conferences – Company Announcement - Financial Times

May 28, 2025
pulisher
May 28, 2025

Viking Therapeutics Lines Up Presentations at Goldman Sachs, William Blair Healthcare Conferences - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Viking Therapeutics Holds Annual Stockholders Meeting - TipRanks

May 27, 2025
pulisher
May 27, 2025

Viking Therapeutics: Buy It For The Future And Ignore The Noise (NASDAQ:VKTX) - Seeking Alpha

May 27, 2025
pulisher
May 25, 2025

(VKTX) On The My Stocks Page - news.stocktradersdaily.com

May 25, 2025
pulisher
May 24, 2025

Better Weight Loss Stock: Amgen or Viking Therapeutics? - MSN

May 24, 2025
pulisher
May 22, 2025

Viking Therapeutics: Weight-Loss Story Remains Intact (NASDAQ:VKTX) - Seeking Alpha

May 22, 2025
pulisher
May 22, 2025

Bank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World

May 22, 2025
pulisher
May 20, 2025

Viking Therapeutics: A High Potential Biotech Play With Manageable Risks (NASDAQ:VKTX) - Seeking Alpha

May 20, 2025
pulisher
May 20, 2025

Viking Therapeutics: Near-Term Catalysts And Competitor Readouts - Seeking Alpha

May 20, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World

May 18, 2025
pulisher
May 17, 2025

Viking Therapeutics (VKTX) Stock Rises Amid Novo Nordisk CEO Cha - GuruFocus

May 17, 2025
pulisher
May 17, 2025

Why Viking Therapeutics Stock Bumped 3% Higher Today - Mitrade

May 17, 2025

Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Viking Therapeutics Inc-Aktie (VKTX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Rouan Sarah Kathryn
Director
Mar 31 '25
Buy
24.15
1,240
29,943
1,240
Lian Brian
President & CEO
Jan 06 '25
Sale
42.75
194,490
8,313,601
2,366,570
Mancini Marianna
Chief Operating Officer
Jan 06 '25
Sale
42.75
54,215
2,317,599
374,134
ZANTE GREG
Chief Financial Officer
Jan 06 '25
Sale
42.75
50,309
2,150,595
165,259
$20.68
price down icon 2.27%
$35.40
price up icon 1.55%
$20.39
price down icon 0.83%
$105.42
price up icon 2.67%
$103.01
price down icon 3.30%
biotechnology ONC
$257.51
price up icon 4.22%
Kapitalisierung:     |  Volumen (24h):